The Risks and Benefits of Indacaterol - The FDA's Review

被引：37

作者：

Chowdhury, Badrul A. ^{[1
]}

Seymour, Sally M. ^{[1
]}

Michele, Theresa M. ^{[1
]}

Durmowicz, Anthony G. ^{[1
]}

Liu, Dongmei ^{[2
]}

Rosebraugh, Curtis J. ^{[3
]}

机构：

[1] US FDA, Div Pulm Allergy & Rheumatol Prod, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD USA

[2] US FDA, Off Biostat, Ctr Drug Evaluat & Res, Silver Spring, MD USA

[3] US FDA, Off Drug Evaluat 2, Ctr Drug Evaluat & Res, Silver Spring, MD USA

来源：

关键词：

D O I：

10.1056/NEJMp1109621

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：2247 / 2249

页数：3

共 5 条

[1]

[Anonymous], DRUGS FDA FDA APPR D

[2]

[Anonymous], HUM MED ONBR BREEZH

Barnes, Peter J. ;

Pocock, Stuart J. ;

Magnussen, Helgo ;

Iqbal, Amir ;

Kramer, Benjamin ;

Higgins, Mark ;

Lawrence, David .

Chowdhury, Badrul A. ;

Dal Pan, Gerald .

[5]

*FOOD DRUG ADM, M MAT MARCH 8 2011 M